These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28236988)

  • 1. [What can we expect from clinical trials in psychiatry?].
    Marsot A; Boucherie Q; Kheloufi F; Riff C; Braunstein D; Dupouey J; Guilhaumou R; Zendjidjian X; Bonin-Guillaume S; Fakra E; Guye M; Jirsa V; Azorin JM; Belzeaux R; Adida M; Micallef J; Blin O
    Encephale; 2016 Dec; 42(6S):S2-S6. PubMed ID: 28236988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics in psychiatric care, a call for uptake of available applications.
    Lunenburg CATC; Gasse C
    Psychiatry Res; 2020 Oct; 292():113336. PubMed ID: 32739644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trials in psychiatry: present status and prospects].
    Azorin JM; Belzeaux R; Adida M
    Encephale; 2016 Dec; 42(6S):S1. PubMed ID: 28236985
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenomics in psychiatry: clinical issues to be considered.
    Licinio J; Wong ML
    Mol Psychiatry; 2005 Jul; 10(7):615. PubMed ID: 15976808
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modeling for clinical trial in psychiatry: rationale, benefits and limitations].
    Simon N; Azorin JM; Belzeaux R; Adida M; Kaladjian A
    Encephale; 2016 Dec; 42(6S):S7-S11. PubMed ID: 28236996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for practical clinical trials in psychiatry.
    March JS; Silva SG; Compton S; Shapiro M; Califf R; Krishnan R
    Am J Psychiatry; 2005 May; 162(5):836-46. PubMed ID: 15863782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What role for paraclinical investigations within clinical trials conducted in psychiatric patients?].
    Kaladjian A; Adida M; Simon N; Belzeaux R; Blin O; Fakra E; Azorin JM
    Encephale; 2016 Dec; 42(6S):S47-S50. PubMed ID: 28236993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials in psychiatry.
    Johnson AL
    Psychol Med; 1983 Feb; 13(1):1-8. PubMed ID: 6844455
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the role of pharmacogenetics in clinical psychiatry?
    Lombard J; Doraiswamy PM
    Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):1-4. PubMed ID: 23189950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing.
    Drozda K; Pacanowski MA
    Pharmacotherapy; 2017 Sep; 37(9):1000-1004. PubMed ID: 28605049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future.
    Preskorn SH
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):85-94. PubMed ID: 16785276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does study design explain the relationship between conflict of interest and positive outcome in clinical trials in psychiatry?
    Wu Y; Deboeck P; Joseph M; Hwang C; Perlis CS; Perlis RH
    J Clin Psychopharmacol; 2009 Dec; 29(6):609-11. PubMed ID: 19910733
    [No Abstract]   [Full Text] [Related]  

  • 13. How biomarkers will change psychiatry: from clinical trials to practice. Part I: introduction.
    Macaluso M; Preskorn SH
    J Psychiatr Pract; 2012 Mar; 18(2):118-21. PubMed ID: 22418402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What place for placebo in clinical trials conducted on psychiatric patients?].
    Cermolacce M; Belzeaux R; Adida M; Micoulaud Franchi JA; Fakra E; Azorin JM
    Encephale; 2016 Dec; 42(6S):S18-S25. PubMed ID: 28236987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials in psychiatry: background and statistical perspective.
    Johnson T
    Stat Methods Med Res; 1998 Sep; 7(3):209-34. PubMed ID: 9803523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Black box" pharmacogenetic decision-support tools in psychiatry.
    Bousman CA; Eyre HA
    Braz J Psychiatry; 2020 Apr; 42(2):113-115. PubMed ID: 31994639
    [No Abstract]   [Full Text] [Related]  

  • 17. Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders.
    Murphy SA; Oslin DW; Rush AJ; Zhu J;
    Neuropsychopharmacology; 2007 Feb; 32(2):257-62. PubMed ID: 17091129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coming-of-age of pharmacogenetic testing in clinical psychiatry.
    Yoshida K; Müller DJ; Kennedy JL
    Psychiatry Clin Neurosci; 2019 May; 73(5):203. PubMed ID: 31045316
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicians' perceptions of pharmacogenomics use in psychiatry.
    Chan CY; Chua BY; Subramaniam M; Suen EL; Lee J
    Pharmacogenomics; 2017 Apr; 18(6):531-538. PubMed ID: 28290747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors contributing to failed trials of new agents: can technology prevent some problems?
    Greist JH; Mundt JC; Kobak K
    J Clin Psychiatry; 2002; 63 Suppl 2():8-13. PubMed ID: 15453008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.